Position in FHTX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$7,679,953
+$157,376 QoQ
Shares Held
1,573,761
0.0% QoQ
Ownership
2.65%
of shares outstanding
% of Portfolio
2.49%
of 13F equity value
Holder Rank
#7
of 102 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in FHTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Euclidean Capital LLC holds $27,571,414 across 6 Biotechnology names. FHTX ranks #2 (27.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ORIC |
Oric Pharmaceuticals, Inc.
|
989,410 | $10,715,310 | |
| 2 | FHTX |
Foghorn Therapeutics Inc.
This page
|
1,573,761 | $7,679,953 | |
| 3 | PMVP |
PMV Pharmaceuticals, Inc.
|
2,627,643 | $3,521,041 | |
| 4 | ALEC |
Alector, Inc.
|
1,307,858 | $2,628,794 | |
| 5 | SRZN |
Surrozen, Inc./DE
|
258,529 | $2,275,711 | |
| 6 | TNYA |
Tenaya Therapeutics, Inc.
|
1,015,705 | $750,605 |
All Filings in FHTX
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $7,679,953 | 1,573,761 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $7,522,577 | 1,573,761 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $8,498,309 | 1,573,761 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $7,695,691 | 1,573,761 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $7,396,676 | 1,573,761 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $5,744,227 | 1,573,761 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $7,428,151 | 1,573,761 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $14,651,714 | 1,573,761 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $9,049,125 | 1,573,761 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $10,559,936 | 1,573,761 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $10,150,758 | 1,573,761 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $7,868,805 | 1,573,761 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $11,079,277 | 1,573,761 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $7,819,818 | 1,261,261 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $8,046,845 | 1,261,261 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $10,821,619 | 1,261,261 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $17,153,149 | 1,261,261 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $19,209,005 | 1,261,261 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $28,845,039 | 1,261,261 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $17,569,365 | 1,261,261 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $13,457,654 | 1,261,261 | Shares | Sole | 2021-11-15 | |
| 2021-03-31 | $16,623,419 | 1,261,261 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $25,565,760 | 1,261,261 | Shares | Sole | 2021-02-12 | |
| No filing history on record for this holder in this stock. | ||||||